This study will use high throughput DNA sequencing methods to characterize the bacteria found on mammalian companion animals and their human household members, with an emphasis on methicillin-resistant Staphylococcus species.
This study investigates the therapeutic relevance of targeting the Wnt signaling pathways in canine malignant melanoma.
The aim of this study is to discover drugs that will work against cancer stem cells of an insulin-producing endocrine pancreatic tumor (insulinoma), thereby improving the prognosis of dogs suffering from insulinoma.
This pilot study will determine the dose and schedule of rapamycin, a promising new adjunct cancer drug.
This study will evaluate dogs with heart disease for a common genetic variant to determine whether this variant affects their ability to respond to heart medications.
This study investigates better postsurgical pain-management strategies for dogs after castration.
This study evaluates a new therapeutic agent designed to inhibit the survivin protein in canine lymphoma.
